1. Home
  2. CYPH vs AIRG Comparison

CYPH vs AIRG Comparison

Compare CYPH & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.59

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$5.72

Market Cap

87.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
AIRG
Founded
2011
1995
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
87.5M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CYPH
AIRG
Price
$0.59
$5.72
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
1.6M
80.6K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.65
EPS
N/A
N/A
Revenue
N/A
$51,779,000.00
Revenue This Year
N/A
$10.31
Revenue Next Year
N/A
$20.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$3.00
52 Week High
$3.70
$7.66

Technical Indicators

Market Signals
Indicator
CYPH
AIRG
Relative Strength Index (RSI) 42.37 39.36
Support Level $0.58 $3.82
Resistance Level $0.79 $6.34
Average True Range (ATR) 0.05 0.27
MACD -0.00 -0.00
Stochastic Oscillator 22.89 30.59

Price Performance

Historical Comparison
CYPH
AIRG

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About AIRG Airgain Inc.

Airgain Incs a provider of advance wireless connectivity solutions. It is focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. It mission is to connect the world through integrated, and optimized wireless solutions. Companies' diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While historically recognized for high-performance radio frequency (RF) components, Airgain is increasingly delivering integrated, system-level connectivity solutions that combine hardware, software, and cloud management. The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings suburbs.

Share on Social Networks: